## Diagnostic Approach to PCP in Advanced HIV **Key Point:** In resource-limited settings such as most Indian centers, **induced sputum examination with Giemsa or silver stain** is the recommended first-line investigation for PCP. It is non-invasive, cost-effective, and has a sensitivity of 50–90% when properly performed. ### PCP Diagnosis Hierarchy **High-Yield:** The diagnostic algorithm depends on clinical suspicion, CD4 count, and available resources: | Investigation | Sensitivity | Specificity | When Used | Limitations | |---|---|---|---|---| | **Induced sputum (Giemsa/silver/GMS)** | 50–90% | >95% | **First-line; non-invasive** | Operator-dependent; may miss low organism burden | | **BAL with IF stain** | 95–100% | >95% | Gold standard; used if sputum negative or unavailable | Invasive; requires bronchoscopy; higher cost | | **(1→3)-β-D-glucan serum** | 80–95% | 90–95% | Supportive adjunct | Not specific for PCP; elevated in other fungal infections | | **HRCT chest** | High | Low | Assesses severity; not diagnostic | Non-specific pattern | ### Why Induced Sputum is the Answer Here 1. **Non-invasive:** No bronchoscopy required — critical in resource-limited settings 2. **Adequate sensitivity (50–90%):** Sufficient for clinical decision-making in most Indian centers 3. **Cost-effective and rapid:** Results within hours to 1 day 4. **Practical first step:** A positive result confirms PCP; a negative result with high clinical suspicion (CD4 <200, bilateral infiltrates, elevated LDH) warrants escalation to BAL **Clinical Pearl:** BAL with immunofluorescence is the **gold standard** (sensitivity 95–100%) and is preferred in high-resource settings or when induced sputum is negative. However, the question asks for the **most appropriate** investigation in a Delhi patient — implying a resource-conscious, stepwise approach where induced sputum precedes bronchoscopy. This is consistent with Indian national ART guidelines and WHO recommendations for opportunistic infection management. ### Why Not the Other Options? - **Option A (HRCT):** Bilateral ground-glass opacities are suggestive but non-specific; cannot confirm PCP microbiologically. - **Option B (Serum β-D-glucan):** Sensitive but not specific — elevated in Candida, Aspergillus, and other fungi; cannot confirm PCP alone. - **Option C (BAL with immunofluorescence):** Gold standard but invasive; reserved for cases where induced sputum is negative or unavailable, or in high-resource settings. **Mnemonic: PCP Staining Methods — GIFS** - **G**iemsa stain (cysts visible) - **I**mmunofluorescence (most sensitive; monoclonal antibodies) - **F**ontana-Masson / silver stain (cyst wall stains dark) - **S**ilver stain — GMS/Grocott (gold standard for morphology) [cite: Harrison's Principles of Internal Medicine, 21e, Ch 197; WHO Guidelines on Opportunistic Infections in HIV; NACO ART Guidelines India 2021]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.